Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003924-21Phase 4Completed
Phase 4, randomised, single-blind trial of alendronate in osteoporosis (2 arms), sponsored by University of Nottingham. Primary endpoints: Oesophageal transit time and Incidences of tablet sticking. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003924-21.